Inhibition of 5α-reductase in the rat prostate by Cimicifuga racemosa
Autor: | Paul Thelen, L. Pitzel, Dana Seidlova-Wuttke, Wolfgang Wuttke |
---|---|
Rok vydání: | 2006 |
Předmět: |
medicine.medical_specialty
medicine.drug_class Black cohosh Antiandrogen General Biochemistry Genetics and Molecular Biology 03 medical and health sciences chemistry.chemical_compound Prostate cancer 0302 clinical medicine Prostate Internal medicine LNCaP medicine Testosterone 030304 developmental biology 0303 health sciences business.industry Obstetrics and Gynecology Androgen medicine.disease 3. Good health medicine.anatomical_structure Endocrinology chemistry 030220 oncology & carcinogenesis Finasteride business |
Zdroj: | Maturitas. 55:S75-S82 |
ISSN: | 0378-5122 |
DOI: | 10.1016/j.maturitas.2006.06.019 |
Popis: | Objectives Prostate cancers and many thereof derived cell lines, as the LNCaP cells, grow androgen-dependent. In vivo testosterone is locally converted by 5α-reductase to 5α-dihydrotestosterone (5α-DHT) which is the major androgenic principle in prostates and seminal vesicles. The occurrence of prostate cancer and growth of LNCaP cells can be effectively inhibited by finasteride, a synthetic 5α-reductase inhibitor and by a black cohosh (Cimicifuga racemosa, CR) extract. In the present contribution we tested whether the aqueous/ethanolic C. racemosa extract BNO 1055 contains 5α-reductase inhibitors. Methods Immature 24-day-old male rats were fed with testosterone (T)-containing food and injected with 30 mg CR BNO 1055 or 0.5 mg finasteride for 5 days. Average daily T-uptake was 39 mg/animal. Other animals remained untreated or received vehicle injections only. Results In comparison to totally untreated rats the testosterone treatment increased weight of prostates and seminal vesicles 3–5-fold and this proliferation was largely and equipotently inhibited by finasteride and CR BNO 1055. 5α-Dihydrotestosterone concentrations in prostate tissue extracts were also reduced by both compounds and the testosterone-upregulated androgen receptor and insulin like growth factor I gene expression inhibited in the seminals vesicles. Conclusion Taken together, these results indicate that the CR extract BNO 1055 contains one or more potent 5α-reductase inhibitors which may make this extract suitable for the prevention and treatment of prostate cancer and possibly of benign prostate hyperplasia (BPH). |
Databáze: | OpenAIRE |
Externí odkaz: |